Neurobiology of COVID-19: how can the virus affect the brain?

Detalhes bibliográficos
Autor(a) principal: Generoso,Jaqueline S.
Data de Publicação: 2021
Outros Autores: Barichello de Quevedo,João L., Cattani,Matias, Lodetti,Bruna F., Sousa,Lucas, Collodel,Allan, Diaz,Alexandre P., Dal-Pizzol,Felipe
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000600650
Resumo: Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), which has been declared a public health emergency of international interest, with confirmed cases in most countries. COVID-19 presents manifestations that can range from asymptomatic or mild infections up to severe manifestations that lead to hospitalization and death. A growing amount of evidence indicates that the virus may cause neuroinvasion. Postmortem brain study findings have included edema, hemorrhage, hydrocephalus, atrophy, encephalitis, infarcts, swollen axons, myelin loss, gliosis, neuronal satellitosis, hypoxic-ischemic damage, arteriolosclerosis, leptomeningeal inflammation, neuronal loss, and axon degeneration. In addition, the COVID-19 pandemic is causing dangerous effects on the mental health of the world population, some of which can be attributed to its social impact (social distancing, financial issues, and quarantine). There is also a concern that environmental stressors, enhanced by psychological factors, are contributing to the emergence of psychiatric outcomes during the pandemic. Although clinical studies and diagnosing SARS-CoV-2-related neurological disease can be challenging, they are necessary to help define the manifestations and burden of COVID-19 in neurological and psychiatric symptoms during and after the pandemic. This review aims to present the neurobiology of coronavirus and postmortem neuropathological hallmarks.
id ABP-1_40369587e9c74facdd8c9735f0aed3a8
oai_identifier_str oai:scielo:S1516-44462021000600650
network_acronym_str ABP-1
network_name_str Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
repository_id_str
spelling Neurobiology of COVID-19: how can the virus affect the brain?Coronavirus-2COVID-19SARS-CoV-2neurobiologypsychiatric disordersSevere acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), which has been declared a public health emergency of international interest, with confirmed cases in most countries. COVID-19 presents manifestations that can range from asymptomatic or mild infections up to severe manifestations that lead to hospitalization and death. A growing amount of evidence indicates that the virus may cause neuroinvasion. Postmortem brain study findings have included edema, hemorrhage, hydrocephalus, atrophy, encephalitis, infarcts, swollen axons, myelin loss, gliosis, neuronal satellitosis, hypoxic-ischemic damage, arteriolosclerosis, leptomeningeal inflammation, neuronal loss, and axon degeneration. In addition, the COVID-19 pandemic is causing dangerous effects on the mental health of the world population, some of which can be attributed to its social impact (social distancing, financial issues, and quarantine). There is also a concern that environmental stressors, enhanced by psychological factors, are contributing to the emergence of psychiatric outcomes during the pandemic. Although clinical studies and diagnosing SARS-CoV-2-related neurological disease can be challenging, they are necessary to help define the manifestations and burden of COVID-19 in neurological and psychiatric symptoms during and after the pandemic. This review aims to present the neurobiology of coronavirus and postmortem neuropathological hallmarks.Associação Brasileira de Psiquiatria2021-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000600650Brazilian Journal of Psychiatry v.43 n.6 2021reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABP10.1590/1516-4446-2020-1488info:eu-repo/semantics/openAccessGeneroso,Jaqueline S.Barichello de Quevedo,João L.Cattani,MatiasLodetti,Bruna F.Sousa,LucasCollodel,AllanDiaz,Alexandre P.Dal-Pizzol,Felipeeng2021-12-10T00:00:00Zoai:scielo:S1516-44462021000600650Revistahttp://www.bjp.org.br/ahead_of_print.asphttps://old.scielo.br/oai/scielo-oai.php||rbp@abpbrasil.org.br1809-452X1516-4446opendoar:2021-12-10T00:00Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)false
dc.title.none.fl_str_mv Neurobiology of COVID-19: how can the virus affect the brain?
title Neurobiology of COVID-19: how can the virus affect the brain?
spellingShingle Neurobiology of COVID-19: how can the virus affect the brain?
Generoso,Jaqueline S.
Coronavirus-2
COVID-19
SARS-CoV-2
neurobiology
psychiatric disorders
title_short Neurobiology of COVID-19: how can the virus affect the brain?
title_full Neurobiology of COVID-19: how can the virus affect the brain?
title_fullStr Neurobiology of COVID-19: how can the virus affect the brain?
title_full_unstemmed Neurobiology of COVID-19: how can the virus affect the brain?
title_sort Neurobiology of COVID-19: how can the virus affect the brain?
author Generoso,Jaqueline S.
author_facet Generoso,Jaqueline S.
Barichello de Quevedo,João L.
Cattani,Matias
Lodetti,Bruna F.
Sousa,Lucas
Collodel,Allan
Diaz,Alexandre P.
Dal-Pizzol,Felipe
author_role author
author2 Barichello de Quevedo,João L.
Cattani,Matias
Lodetti,Bruna F.
Sousa,Lucas
Collodel,Allan
Diaz,Alexandre P.
Dal-Pizzol,Felipe
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Generoso,Jaqueline S.
Barichello de Quevedo,João L.
Cattani,Matias
Lodetti,Bruna F.
Sousa,Lucas
Collodel,Allan
Diaz,Alexandre P.
Dal-Pizzol,Felipe
dc.subject.por.fl_str_mv Coronavirus-2
COVID-19
SARS-CoV-2
neurobiology
psychiatric disorders
topic Coronavirus-2
COVID-19
SARS-CoV-2
neurobiology
psychiatric disorders
description Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), which has been declared a public health emergency of international interest, with confirmed cases in most countries. COVID-19 presents manifestations that can range from asymptomatic or mild infections up to severe manifestations that lead to hospitalization and death. A growing amount of evidence indicates that the virus may cause neuroinvasion. Postmortem brain study findings have included edema, hemorrhage, hydrocephalus, atrophy, encephalitis, infarcts, swollen axons, myelin loss, gliosis, neuronal satellitosis, hypoxic-ischemic damage, arteriolosclerosis, leptomeningeal inflammation, neuronal loss, and axon degeneration. In addition, the COVID-19 pandemic is causing dangerous effects on the mental health of the world population, some of which can be attributed to its social impact (social distancing, financial issues, and quarantine). There is also a concern that environmental stressors, enhanced by psychological factors, are contributing to the emergence of psychiatric outcomes during the pandemic. Although clinical studies and diagnosing SARS-CoV-2-related neurological disease can be challenging, they are necessary to help define the manifestations and burden of COVID-19 in neurological and psychiatric symptoms during and after the pandemic. This review aims to present the neurobiology of coronavirus and postmortem neuropathological hallmarks.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000600650
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000600650
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1516-4446-2020-1488
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
dc.source.none.fl_str_mv Brazilian Journal of Psychiatry v.43 n.6 2021
reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
instname:Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
instname_str Associação Brasileira de Psiquiatria (ABP)
instacron_str ABP
institution ABP
reponame_str Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
collection Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
repository.name.fl_str_mv Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)
repository.mail.fl_str_mv ||rbp@abpbrasil.org.br
_version_ 1754212560484171776